Alexander HR - Search Results

1

Targeting vaccinia to solid tumors with local hyperthermia.

Chang E, Chalikonda S, Friedl J, Xu H, Phan GQ, Marincola FM, Alexander HR, Bartlett DL. Chang E, et al. Among authors: alexander hr. Hum Gene Ther. 2005 Apr;16(4):435-44. doi: 10.1089/hum.2005.16.435. Hum Gene Ther. 2005. PMID: 15871675

2

Development of a melanoma-specific adenovirus.

McCart JA, Wang ZH, Xu H, Hu Y, Park B, Alexander HR, Bartlett DL. McCart JA, et al. Among authors: alexander hr. Mol Ther. 2002 Oct;6(4):471-80. doi: 10.1006/mthe.2002.0692. Mol Ther. 2002. PMID: 12377188 Free article.

3

Intravenous and isolated limb perfusion delivery of wild type and a tumor-selective replicating mutant vaccinia virus in nonhuman primates.

Naik AM, Chalikonda S, McCart JA, Xu H, Guo ZS, Langham G, Gardner D, Mocellin S, Lokshin AE, Moss B, Alexander HR, Bartlett DL. Naik AM, et al. Among authors: alexander hr. Hum Gene Ther. 2006 Jan;17(1):31-45. doi: 10.1089/hum.2006.17.31. Hum Gene Ther. 2006. PMID: 16409123

4

Thymidine kinase-deleted vaccinia virus expressing purine nucleoside phosphorylase as a vector for tumor-directed gene therapy.

Puhlmann M, Gnant M, Brown CK, Alexander HR, Bartlett DL. Puhlmann M, et al. Among authors: alexander hr. Hum Gene Ther. 1999 Mar 1;10(4):649-57. doi: 10.1089/10430349950018724. Hum Gene Ther. 1999. PMID: 10094208

5

Vaccinia as a vector for tumor-directed gene therapy: biodistribution of a thymidine kinase-deleted mutant.

Puhlmann M, Brown CK, Gnant M, Huang J, Libutti SK, Alexander HR, Bartlett DL. Puhlmann M, et al. Among authors: alexander hr. Cancer Gene Ther. 2000 Jan;7(1):66-73. doi: 10.1038/sj.cgt.7700075. Cancer Gene Ther. 2000. PMID: 10678358

6

Complex interactions between the replicating oncolytic effect and the enzyme/prodrug effect of vaccinia-mediated tumor regression.

McCart JA, Puhlmann M, Lee J, Hu Y, Libutti SK, Alexander HR, Bartlett DL. McCart JA, et al. Among authors: alexander hr. Gene Ther. 2000 Jul;7(14):1217-23. doi: 10.1038/sj.gt.3301237. Gene Ther. 2000. PMID: 10918490

7

Induction of permeability across endothelial cell monolayers by tumor necrosis factor (TNF) occurs via a tissue factor-dependent mechanism: relationship between the procoagulant and permeability effects of TNF.

Friedl J, Puhlmann M, Bartlett DL, Libutti SK, Turner EN, Gnant MF, Alexander HR. Friedl J, et al. Among authors: alexander hr. Blood. 2002 Aug 15;100(4):1334-9. Blood. 2002. PMID: 12149215 Free article.

8

Hepatic vascular isolation and perfusion for patients with progressive unresectable liver metastases from colorectal carcinoma refractory to previous systemic and regional chemotherapy.

Alexander HR Jr, Libutti SK, Bartlett DL, Pingpank JF, Kranda K, Helsabeck C, Beresnev T. Alexander HR Jr, et al. Cancer. 2002 Aug 15;95(4):730-6. doi: 10.1002/cncr.10686. Cancer. 2002. PMID: 12209715 Free article.

9

Augmentation of endothelial cell monolayer permeability by hyperthermia but not tumor necrosis factor: evidence for disruption of vascular integrity via VE-cadherin down-regulation.

Friedl J, Turner E, Alexander HR Jr. Friedl J, et al. Among authors: alexander hr jr. Int J Oncol. 2003 Sep;23(3):611-6. Int J Oncol. 2003. PMID: 12888895

10

Treatment of patients with unresectable primary hepatic malignancies using hyperthermic isolated hepatic perfusion.

Feldman ED, Wu PC, Beresneva T, Helsabeck C, Rodriguez M, Bartlett DL, Libutti SK, Pingpank JF, Alexander HR. Feldman ED, et al. Among authors: alexander hr. J Gastrointest Surg. 2004 Feb;8(2):200-7. doi: 10.1016/j.gassur.2003.11.005. J Gastrointest Surg. 2004. PMID: 15036196

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

309 results

Search Page

Filters